- Conditions
- Pulmonary Embolism With Acute Cor Pulmonale, Pulmonary Embolism, Pulmonary Embolism With Pulmonary Infarction, Pulmonary Embolism Subacute Massive, Right Ventricular Dysfunction, Right Ventricular Failure
- Interventions
- Alteplase, Unfractionated heparin, Placebo, Apixaban
- Drug
- Lead sponsor
- Victor Tapson, MD
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 4 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Los Angeles, California
Source: ClinicalTrials.gov public record
Updated Jun 10, 2021 · Synced May 21, 2026, 11:09 PM EDT